U.S. DOJ reclassifies state‑licensed medical marijuana as a less‑dangerous drug, prompting a market rally.
Aurora Cannabis up ~6% pre‑market, Tilray +9.3% and Canopy Growth +7.3%.
AdvisorShares Pure US Cannabis ETF surged 8% as broader cannabis sector rallied.
Major cannabis tickers WEED +5.82%, TLRY +5.45%, while ACB fell 0.96% and MSOS rose 0.49%.